JP2011525479A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011525479A5 JP2011525479A5 JP2011511735A JP2011511735A JP2011525479A5 JP 2011525479 A5 JP2011525479 A5 JP 2011525479A5 JP 2011511735 A JP2011511735 A JP 2011511735A JP 2011511735 A JP2011511735 A JP 2011511735A JP 2011525479 A5 JP2011525479 A5 JP 2011525479A5
- Authority
- JP
- Japan
- Prior art keywords
- nsaids
- composition
- antihypertensive agents
- diuretic
- oral administration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229940021182 non-steroidal anti-inflammatory drugs Drugs 0.000 claims 13
- 239000002220 antihypertensive agent Substances 0.000 claims 6
- 230000001396 anti-anti-diuretic Effects 0.000 claims 4
- 239000002934 diuretic Substances 0.000 claims 4
- 230000001882 diuretic Effects 0.000 claims 4
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 claims 3
- 229940030609 CALCIUM CHANNEL BLOCKERS Drugs 0.000 claims 2
- 102100015381 PTGS2 Human genes 0.000 claims 2
- 101710040930 PTGS2 Proteins 0.000 claims 2
- 239000000480 calcium channel blocker Substances 0.000 claims 2
- 230000002401 inhibitory effect Effects 0.000 claims 2
- 230000001760 anti-analgesic Effects 0.000 claims 1
- 230000003276 anti-hypertensive Effects 0.000 claims 1
- 230000003110 anti-inflammatory Effects 0.000 claims 1
- 230000001754 anti-pyretic Effects 0.000 claims 1
- 239000002221 antipyretic Substances 0.000 claims 1
- 230000000271 cardiovascular Effects 0.000 claims 1
- 231100000486 side effect Toxicity 0.000 claims 1
Claims (10)
- 抗炎症、鎮痛又は解熱治療に用いるための経口投与組成物であって:
1つ以上の非ステロイド性抗炎症性薬物(NSAIDs)と、
1つ以上の降圧剤と
を有することを特徴とする経口投与組成物。 - 前記1つ以上の降圧剤が非利尿剤を含むことを特徴とする請求項1に記載の経口投与組成物。
- 前記1つ以上の降圧剤が利尿剤を含むことを特徴とする請求項1に記載の経口投与組成物。
- 前記1つ以上のNSAIDsが非選択的なNSAIDを含むことを特徴とする請求項1に記載の経口投与組成物。
- 前記1つ以上のNSAIDsがCOX−2の阻害に特異的なNSAIDを含むことを特徴とする請求項1に記載の経口投与組成物。
- 前記1つ以上の降圧剤がカルシウムチャネルブロッカーである請求項5に記載の経口投与組成物。
- 複数の投与量が長期にわたり被験体に提供される1つ以上の非ステロイド性抗炎症性薬物(NSAIDs)と、
複数の投与量が所定の期間にわたり前記被験体に提供される1つ以上の非利尿性降圧剤と、
を有し、
前記1つ以上の非利尿性降圧剤投与量が、前記1つ以上のNSAIDsの心血管系の副作用を阻止又は低下させるのに十分であることを特徴とする経口投与組成物。 - 前記1つ以上のNSAIDsが、非選択的なNSAIDであることを特徴とする請求項7に記載の方法。
- 前記1つ以上のNSAIDsが、COX−2の阻害に特異的なNSAIDを含むことを特徴とする請求項7に記載の方法。
- 前記1つ以上の降圧剤がカルシウムチャネルブロッカーである請求項9に記載の経口投与組成物。
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5678908P | 2008-05-28 | 2008-05-28 | |
US61/056,789 | 2008-05-28 | ||
US9797208P | 2008-09-18 | 2008-09-18 | |
US61/097,972 | 2008-09-18 | ||
PCT/US2009/044966 WO2009154944A2 (en) | 2008-05-28 | 2009-05-22 | Pharmaceutical formulations and methods of use which combine non-steroidal anti-inflammatory compounds with anti-hypertensive compounds |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2011525479A JP2011525479A (ja) | 2011-09-22 |
JP2011525479A5 true JP2011525479A5 (ja) | 2012-07-05 |
Family
ID=41434626
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2011511735A Pending JP2011525479A (ja) | 2008-05-28 | 2009-05-22 | 非ステロイド性抗炎症性化合物と降圧化合物とを組み合わせた製剤処方及びその使用方法 |
Country Status (7)
Country | Link |
---|---|
US (2) | US20110207724A1 (ja) |
EP (1) | EP2285371A4 (ja) |
JP (1) | JP2011525479A (ja) |
AU (1) | AU2009260632A1 (ja) |
CA (1) | CA2726337A1 (ja) |
MX (1) | MX2010012836A (ja) |
WO (1) | WO2009154944A2 (ja) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3151822A4 (en) * | 2014-06-08 | 2017-11-22 | Autotelic LLC | Fixed dose combination for pain relief without edema |
WO2019067768A2 (en) * | 2017-09-28 | 2019-04-04 | Nevakar, Inc. | FIXED DOSE COMBINATION FORMULATIONS FOR THE TREATMENT OF PAIN |
US20210393553A1 (en) * | 2018-11-01 | 2021-12-23 | Imuneks Farma Ilac Sanayi Ve Ticaret A.S. | Pharmaceutical combinations for the treatment of pain |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5155120A (en) * | 1991-01-14 | 1992-10-13 | Pfizer Inc | Method for treating congestive heart failure |
US20040186155A1 (en) * | 2003-01-30 | 2004-09-23 | Dayno Jeffrey Marc | Combination therapy for the treatment or prevention of migraine |
WO2006102476A2 (en) * | 2005-03-21 | 2006-09-28 | Vicus Therapeutics Spe 1, Llc | Compositions and methods for ameliorating cachexia |
US20070037797A1 (en) * | 2005-08-15 | 2007-02-15 | Hellstrom Harold R | Method of reducing the risk of adverse cardiovascular (CV) events associated with the administration of pharmaceutical agents which favor CV events |
-
2009
- 2009-05-22 US US12/990,724 patent/US20110207724A1/en not_active Abandoned
- 2009-05-22 EP EP09767256A patent/EP2285371A4/en not_active Ceased
- 2009-05-22 MX MX2010012836A patent/MX2010012836A/es unknown
- 2009-05-22 WO PCT/US2009/044966 patent/WO2009154944A2/en active Application Filing
- 2009-05-22 AU AU2009260632A patent/AU2009260632A1/en not_active Abandoned
- 2009-05-22 CA CA2726337A patent/CA2726337A1/en not_active Abandoned
- 2009-05-22 JP JP2011511735A patent/JP2011525479A/ja active Pending
-
2016
- 2016-05-02 US US15/144,188 patent/US20160243134A1/en not_active Abandoned
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Munir et al. | Nonopioid analgesics | |
IL194885A0 (en) | Pharmaceutical combination comprising 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol and an nsaid | |
WO2008040534A3 (en) | Non-mucoadhesive film dosage forms | |
FI3782612T3 (fi) | Sytidiinianalogien oraalisia formulaatioita ja menetelmiä niiden käyttämiseksi | |
WO2011079239A3 (en) | Combination tablet with chewable outer layer | |
MX2009004203A (es) | Combinaciones de paracetamol/ibuprofeno y metodo para su uso. | |
WO2009088414A3 (en) | Oral pharmaceutical dosage forms | |
JP2012502037A5 (ja) | ||
NO20085302L (no) | Farmasoytisk preparat omfattende Amlodipin og Losartan | |
WO2007112274A3 (en) | Formulations of low dose non-steroidal anti-inflammatory drugs and beta-cyclodextrin | |
HRP20171743T1 (hr) | Sastavi i postupci za savladavanje otpornosti na tramadol | |
CL2007002921A1 (es) | Forma solida de dosificacion farmaceutica de administracion oral, que comprende una forma cristalina o amorfa de un compuesto microincluido en un polimero ionico insoluble en agua en proporcion 5:1 a 1:5; y metodo de preparacion. | |
WO2008142572A3 (en) | Controlled release tablet formulation containing magnesium aluminometasilicate | |
DK2043637T3 (da) | Fremgangsmåder og medikamenter til administrering af ibuprofen | |
AR077284A1 (es) | Composiciones de dosis fija farmaceuticas solidas que comprenden irbesartan y amlodipina, su preparacion y su aplicacion terapeutica | |
WO2008106689A3 (en) | Breakthrough pain management | |
JP2011525479A5 (ja) | ||
DK2101730T3 (da) | Galenisk form til transmucosal indgivelse af paracetamol | |
WO2007145863A3 (en) | Sustained release formulation of naltrexone | |
TR200708925A1 (tr) | Kontrollü salım sağlayan flurbiprofen ve kas gevşetici kombinasyonları | |
JP2012041314A5 (ja) | ||
RU2017113827A (ru) | Фармацевтический состав для уменьшения спазмов мочевого пузыря и способ его применения | |
WO2009154944A3 (en) | Pharmaceutical formulations and methods of use which combine non-steroidal anti-inflammatory compounds with anti-hypertensive compounds | |
Day | Another selective COX-2 inhibitor: more questions than answers? | |
JP2012097034A5 (ja) |